Search
for
Sort by
Research 151–180 of 1000+
- Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception
- Montagna Symposium 2013—Light and Skin: How Light Sustains, Damages, Treats, Images and Modifies Skin Biology
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- 675-nm diode laser as an adjuvant treatment for telogen effluvium: case series
- 7. Surgery and Laser
- Acute telogen effluvium associated with SARS-CoV-2 infection
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Effectiveness, Safety and Tolerability of Dheedhi Herbal Shampoo against Alopecia and Seborrheic Dermatitis - A clinical Perspective
- Crohn's Ileocolitis Presenting as Chronic Diffuse Hair Loss
- Management of Toxicities of Targeted Therapies
- Navigating Hair Loss in Medical School: Experiences of 2 Young Black Women
- The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Androgenetic alopecia treatment options are plentiful
- Topical solutions for androgenetic alopecia: evaluating efficacy and safety
- Bempikibart shows its potential for hair regrowth in alopecia areata
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications
- Stressful lie events in alopecia areata patients: A case control study
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use—Reply
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma